Wash-Out Period Determination

Wash-out period determination establishes sufficient time between treatment exposures enabling unbiased assessment. Complete drug elimination from previous exposure prevents confounding. Pharmacokinetic calculations predict elimination timeframes. Bioanalytical confirmation verifies clearance adequacy. Safety margin consideration extends minimum washout.

Regulatory submissions justify washout selection. Trial design incorporates appropriate washout intervals. Compliance monitoring detects premature re-dosing. Clinical outcomes depend on washout adequacy. Post-approval monitoring confirms interval appropriateness.